Belgium· BE-AMP-SAM386723-00
Alli 27 mg
A orlistat product containing orlistat, registered in Belgium by Haleon Ireland Dungarvan. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Orlistat is registered in 16 of 19 countries.
Countries holding a registration under ATC A08AB01 (orlistat), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Orlistat · ATC A08AB01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of orlistat costs, country by country.
Normalised to the WHO defined daily dose (0.36 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Orlistat · price per daily dose (0.36 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.08
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Orlistat
- Manufacturer
- Haleon Ireland Dungarvan
- Country
- Belgium (BE)
- ATC code
- A08AB01
- ATC class
- Orlistat
- Defined daily dose
- 0.36 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
374 interactions on record for orlistat.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Orlistat · interactions on record
374 records
- 9 severe
- 117 moderate
- 8 minor
- 238 info
Most severe, free to view
- TriheptanoinA16AX17severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Orlistat in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainALLI 27 mg COMPRIMIDOS MASTICABLESGlaxo Group Limited
- FinlandAlliGlaxoSmithKline Dungarvan Ltd.
- United KingdomAlli 27mg chewable tabletsHaleon UK Trading Ltd
- IcelandalliGlaxoSmithKline Dungarvan Ltd.
- Swedenalli 27 mg TuggtablettGlaxo Group Ltd
- CzechiaALLIHALEON IRELAND DUNGARVAN LIMITED, Waterford
- IrelandAlliGlaxoSmithKline Dungarvan Limited
- SwitzerlandOrlistat Sandoz, HartkapselnSandoz Pharmaceuticals AG
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Czechia · Orlistat 1 A Pharma, Orlistat Sandoz
- Germany · Orlistat 1 A Pharma, Orlistat Hexal
- Denmark · Orlistat Accord, Orlistat Rivopharm
- Estonia · Orlistat Sandoz
- Spain · Beacita, Elimens
- Finland · Orlistat Sandoz, Orlistat Stada
- France · Orlistat Eg
- United Kingdom (Northern Ireland) · Orlistat, Orlistat Accord-Uk
- Ireland · Orlistat Accord
- Iceland · Alli, Xenical
- Italy · Beacita
- Liechtenstein · Alli, Xenical
- Lithuania · Orlistat Polpharma
- Latvia · Orlistat Polpharma
- Netherlands · Orlistat Sandoz
- Norway · Alli, Orlistat Accord
- Portugal · Orlistato Beacita, Orlistato Ciclum
- Sweden · Beacita, Orlistat Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/90ad0914-9fb0-49ad-8018-c6c2ce612015 GET /v1/drugs/90ad0914-9fb0-49ad-8018-c6c2ce612015?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Chewable tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Alli 27 mg",
"name_fr": "Alli 27 mg",
"name_nl": "Alli 27 mg",
"amp_code": "SAM386723-00",
"strengths": [
"27.0000",
"27.0000",
"27.0000",
"27.0000"
],
"pack_count": 5,
"substances": [
"Orlistat"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Orlistat",
"authorisation_numbers": [
"EU/1/07/401/016",
"EU/1/07/401/013",
"EU/1/07/401/012",
"EU/1/07/401/015",
"EU/1/07/401/014"
]
}See everything about orlistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.